Table 5.
The occurrence of nausea and vomiting during the probiotic treatment.
| Study | Duration of Vomiting (Days) |
Duration of Nausea (Days) |
Nausea Grade (CTCAE 2 3.0, Percentage of Patients, %) |
Vomiting Grade (CTCAE 3.0, Percentage of Patients, %) |
General Result 1 | ||||
|---|---|---|---|---|---|---|---|---|---|
| Study Group | Control Group | Study Group | Control Group | Study Group | Control Group | Study Group | Control Group | ||
| CHILDREN POPULATION | |||||||||
| Chemotherapy treatment | |||||||||
| Reyna-Figueroa J. et al. [38] | up to 6 | up to 7 | up to 7 | up to 7 | N/A | N/A | N/A | N/A | improvement |
| Radiotherapy treatment | |||||||||
| Shu-Xu Du et al. [37] | N/A | N/A | N/A | N/A | I 16.25 II 30 III 16.25 IV 3.75 |
I 12.5 II 36.25 III 26.25 IV 7.5 |
I 6.25 II 16.25 III 12.5 IV 35 |
I 7.5 II 26.25 III 16.25 IV 2.5 |
improvement |
1 Significantly better outcomes in the study group in at least one parameter (α = 0.05); 2 CTCAE—Common Terminology Criteria for Adverse Events.